Chapter 52 ■ Treatment of Retinopathy of Prematurity 373
(2) Administers topical anesthetic
(3) Ensures that all personnel present at the treatment are wearing laser safety goggles
(5) Watches for and treats ocular complications that
may arise during and after the procedure
(6) Follows the baby postoperatively until ROP is
b. Neonatology fellow, attending neonatologist, or
(1) Administers systemic sedative agents (midazolam, fentanyl, ketamine, or a combination)
(2) Monitors patient for and treats any systemic
complications that develop during or after treatment
(3) Provides information to the ophthalmologist
regarding the patient’s overall condition throughout the procedure
c. Assistant to the ophthalmologist
(1) Helps with laser and instruments
(2) Records the treatment parameters used during
(1) Instills dilating drops several times in the hour
(2) Immobilizes the patient during treatment
a. Cardiorespiratory, blood pressure, and pulse oximeter
c. Emergency medications (atropine, epinephrine,
bicarbonate, calcium, phenobarbital)
Note: Precalculation of weight-appropriate doses
d. Topical ocular anesthetic (e.g., tetracaine, proparacaine)
e. Cycloplegic/mydriatic eye drops: Cyclomydril (Alcon
Laboratories, Fort Worth, Texas) (cyclopentolate
hydrochloride 0.2% and phenylephrine hydrochloride 1%) or 0.5% cyclopentolate and 1% or 2.5%
f. Calcium alginate-tipped nasopharyngeal applicators
or Flynn depressor (Fig. 52.4), for scleral depression
g. Balanced salt solution for rewetting cornea during
h. Neonatal eyelid speculum (Fig. 52.4)
Fig. 52.3. Dilation and tortuosity of iris vessels may be seen in
severe threshold retinopathy of prematurity.
Fig. 52.2. Dilated, tortuous vessels end in vascular shunts at a
thickened ridge of fibrovascular tissue. Avascular retina lies anterior to the ridge.
Fig. 52.4. Lid speculae and Flynn depressor.
No comments:
Post a Comment
اكتب تعليق حول الموضوع